Repopulation in radiation oncology: Perspectives of clinical research

International Journal of Radiation Biology

Volumn 79, Issue 7, 2003, Pages 581-585

  Bentzen, S M ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE; CISPLATIN; CYTOTOXIC AGENT; DNA TOPOISOMERASE INHIBITOR; FLUORINE 18; FLUOROURACIL; GEFITINIB; MITOMYCIN C; TAXANE DERIVATIVE;

CANCER RADIOTHERAPY; CELL ACTIVITY; CELL PROLIFERATION; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CORRELATION ANALYSIS; DATA ANALYSIS; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TISSUE REGENERATION; TUMOR BIOPSY; TUMOR CELL; TUMOR GROWTH;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS;

EID: 0142209194     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000310001597002     Document Type: Conference Paper

References (18)

1. ANG, K. K., TROTTI, A., BROWN, B. W., GARDEN, A. S., FOOTE, R. L., MORRISON, W. H., GEARA, F. B., KLOTCH, D. W., GOEPFERT, H. and PETERS, L. J., 2001, Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. International Journal of Radiation Oncology Biology Physics, 51, 571-578.
2. AWWAD, H. K., LOTAYEE, M., SHOUMAN, T., BEGG, A. C., WILSON, G., BENTZEN, S. M., ABD EL-MONEIM, H. and EISSA, S., 2002, Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. British Journal of Cancer, 86, 517-523.
3. BAUMANN, M., BENTZEN, S. M., DOERR, W., JOINER, M. C., SAUNDERS, M., TANNOCK, I. F. and THAMES, H. D., 2001, The translational research chain: is it delivering the goods? International Journal of Radiation Oncology Biology Physics, 49, 345-351.
4. BENTZEN, S. M., 1993, Time-dose relationships for human tumors: estimation from non-randomized studies. In H. P. Beck-Bornholt (ed.), Current Topics in Clinical Radiobiology of Tumours: Medical Radiology (Berlin: Springer), pp. 11-26.
5. BENTZEN, S. M., SAUNDERS, M. I. and DISCHE, S., 1999, Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiotherapy and Oncology, 53, 219-226.
6. BENTZEN, S. M., SAUNDERS, M. I. and DISCHE, S., 2002, From CHART to CHARTWEL in non-small cell lung cancer: clinical radiobiological modelling of the expected change in outcome. Clinical Oncology (Royal College of Radiology), 14, 372-381.
7. BENTZEN, S. M., SAUNDERS, M. I., DISCHE, S. and BOND, S. J., 2001, Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiotherapy and Oncology, 60, 123-135.
8. BERNIER, J. and BENTZEN, S. M., 2003, Altered fractionation and combined radio-chemotherapy approaches, pioneering new opportunities in head and neck oncology. European Journal of Cancer, 39, 560-571.
9. DISCHE, S., SAUNDERS, M. I., BARRETT, A., HARVEY, A., GIBSON, D. and PARMAR, M., 1997, A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiotherapy and Oncology, 44, 123-136.
10. DORR, W. and HENDRY, J. H., 2001, Consequential late effects in normal tissues. Radiotherapy and Oncology, 61, 223-231.
11. FARRELL, C. L., REX, K. L., CHEN, J. N., BREADY, J. V., DIPALMA, C. R., KAUFMAN, S. A., RATTAN. A., SCULLY, S. and LACEY, D. L., 2002, The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Proliferation, 35(Suppl. 1), 78-85.
12. HANSEN, O., OVERGAARD, J., HANSEN, H. S., OVERGAARD, M., HOYER, M., JORGENSEN, K. E., BASTHOLT, L. and BERTHELSEN, A., 1997, Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiotherapy and Oncology, 43, 47-51.
13. JAMES, N. D., ROBERTSON, G., SQUIRE, C. J., FORBES, H. and JONES, K., 2003, A national audit of radiotherapy in head and neck cancer. Clinical Oncology, 15, 41-46.
14. PIGNON, J. P., BOURHIS, J., DOMENGE, C. and DESIGNE, L., 2000, Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet, 355, 949-955.
15. SAUNDERS, M. I., DISCHE, S., BARRETT, A., HARVEY, A., GIBSON, D. and PARMAR, M., 1997, Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet, 350, 161-165.
16. SAUNDERS, M. I., ROJAS, A., LYN, B. E., WILSON, E. and PHILLIPS, H, 2002, Dose-escalation with CHARTWEL (continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment of locally advanced non-small cell lung cancer. Clinical Oncology (Royal College of Radiology), 14, 352-360.
17. STONE, H. B., MCBRIDE, W. H. and COLEMAN, C. N., 2002, Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland, September 6-8, 2000. Radiation Research, 157, 204-223.
18. VESSELLE, H., GRIERSON, J., MUZI, M., PUGSLEY, J. M., SCHMIDT, R. A., RABINOWITZ, P., PETERSON, L. M., VALLIERES, E. and WOOD, D. E., 2002, In vivo validation of 3′deoxy-3′-[(18)F]fluorothymidine ([(1S)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clinical Cancer Research, 8, 3315-3323.